Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTXR | ZTS | TAK | UTHR | NBIX |
| Company | Citius Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.2800 | 166.98 | 16.04 | 263.50 | 108.67 |
| High | 1.3450 | 167.69 | 16.07 | 263.97 | 109.52 |
| Low | 1.2700 | 164.50 | 15.94 | 258.17 | 108.03 |
| Last | 1.3200 | 165.18 | 16.03 | 259.68 | 108.25 |
| Change | +0.0100 | -3.06 | -0.07 | -4.55 | -0.13 |
| % Change | +0.76% | -1.82% | -0.43% | -1.72% | -0.12% |
| Volume | 770,300 | 1,831,700 | 3,671,300 | 217,900 | 490,000 |
| 20-Day Average Volume | 1,298,470 | 2,311,490 | 3,251,180 | 344,590 | 823,800 |
| Previous Close | 1.3100 | 168.24 | 16.10 | 264.23 | 108.38 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0801 | 157.03 | 15.87 | 265.84 | 112.72 |
| 20-Day Raw Stochastic | 77.46% | 65.96% | 73.66% | 17.61% | 10.80% |
| 20-Day Relative Strength | 61.05% | 62.11% | 62.41% | 44.63% | 39.88% |
| Weighted Alpha | +4.00 | -10.90 | +16.50 | +27.10 | +30.50 |
| Today's Opinion | 40% Buy | 40% Buy | 88% Buy | 40% Buy | 8% Sell |
| Previous Opinion | 24% Buy | 40% Buy | 88% Buy | 40% Buy | 8% Sell |
| Last Month's Opinion | 56% Sell | 80% Sell | 72% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.35% since 01/20/23 | +0.84% since 01/20/23 | -1.48% since 01/20/23 | -0.77% since 01/20/23 | -2.79% since 01/20/23 |
| Low | 1.1400 on 01/25/23 | 145.20 on 01/24/23 | 15.94 on 01/27/23 | 255.52 on 01/25/23 | 107.54 on 01/24/23 |
| High | 1.4000 on 01/23/23 | 177.39 on 01/24/23 | 16.30 on 01/23/23 | 266.05 on 01/25/23 | 112.25 on 01/23/23 |
| 1-Month | |||||
| %Chg | +63.98% since 12/27/22 | +13.68% since 12/27/22 | +3.96% since 12/27/22 | -5.14% since 12/27/22 | -8.98% since 12/27/22 |
| Low | 0.7700 on 12/30/22 | 141.52 on 01/06/23 | 15.27 on 01/10/23 | 255.52 on 01/25/23 | 106.22 on 01/10/23 |
| High | 1.4800 on 01/20/23 | 177.39 on 01/24/23 | 16.30 on 01/20/23 | 279.14 on 01/06/23 | 125.01 on 01/06/23 |
| 3-Month | |||||
| %Chg | +24.53% since 10/27/22 | +9.29% since 10/27/22 | +22.93% since 10/27/22 | +15.00% since 10/27/22 | -4.92% since 10/27/22 |
| Low | 0.7700 on 12/30/22 | 124.15 on 11/03/22 | 12.99 on 11/03/22 | 225.19 on 10/28/22 | 106.22 on 01/10/23 |
| High | 1.4800 on 01/20/23 | 177.39 on 01/24/23 | 16.30 on 01/20/23 | 283.09 on 12/09/22 | 129.29 on 12/01/22 |
| 6-Month | |||||
| %Chg | +47.32% since 07/27/22 | -6.93% since 07/27/22 | +9.12% since 07/27/22 | +12.42% since 07/27/22 | +13.29% since 07/27/22 |
| Low | 0.7700 on 12/30/22 | 124.15 on 11/03/22 | 12.28 on 10/21/22 | 201.65 on 09/22/22 | 91.53 on 07/28/22 |
| High | 1.4800 on 01/20/23 | 183.80 on 07/28/22 | 16.30 on 01/20/23 | 283.09 on 12/09/22 | 129.29 on 12/01/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 192,999 | 76,985,768 | 49,704,576 | 11,835,432 | 10,406,506 |
| Shares Outstanding, K | 146,211 | 466,072 | 3,100,722 | 45,577 | 96,134 |
| Annual Sales | 0 | 7,776,000,000 | 31,764,150,000 | 1,685,500,000 | 1,133,500,000 |
| Annual Net Income | -33,640,000 | 2,037,000,000 | 2,047,530,000 | 475,800,000 | 89,600,000 |
| Last Quarter Sales | 0 | 2,002,000,000 | 7,216,610,000 | 516,000,000 | 387,900,000 |
| Last Quarter Net Income | -7,990,740 | 529,000,000 | 444,540,000 | 239,300,000 | 68,500,000 |
| 60-Month Beta | 1.21 | 0.73 | 0.65 | 0.62 | 0.54 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 12/22/22 | 1.21 on 11/03/22 | 0.52 on 10/27/22 | 4.91 on 11/02/22 | 0.69 on 11/01/22 |
| Latest Earnings Date | 02/09/23 | 02/14/23 | 02/02/23 | 02/23/23 | 02/06/23 |
| Most Recent Dividend | N/A | 0.375 on 01/19/23 | 0.270 on 09/29/22 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/19/23 | 09/29/22 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 35.57 | 8.05 | 17.97 | 190.14 |
